Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LANSING, MI--(Marketwired - January 20, 2016) - Heat Miser appeared to get the upper hand, as unseasonably warm weather helped push Michigan retailers' holiday sales below forecasts. Sales...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2016) - Tinka Resources Limited ("Tinka" or the "Company") (TSX VENTURE:TK)(OTC PINK:TKRFF) is pleased to announce results of the...
-
Albany, NY, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has recently published report, detailing the present dynamics and growth opportunities for the global smart and...
-
EVLI BANK PLC STOCK EXCHANGE RELEASE JANUARY 20, 2016, AT 1.30 PM Invitation to investor and analyst meeting: Evli Bank Plc's preliminary result for 2015 Evli Bank Plc will publish its preliminary...
-
EVLI PANKKI OYJ PÖRSSITIEDOTE 20.1.2016 klo 13.30Kutsu sijoittaja- ja analyytikkotilaisuuteen: Evli Pankki Oyj:n alustava tulos tilikaudelta 2015Evli Pankki Oyj julkistaa alustavan tuloksensa...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2016) - B2Gold Corp. (TSX:BTO)(NYSE MKT:BTG)(NAMIBIAN:B2G)("B2Gold" or the "Company") is pleased to announce an exploration update...
-
EDINBURGH, UK, Jan. 20, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Global analyst house Ovum have awarded IT Service Management (ITSM) leader Axios Systems the highest rating in four key assessment...
-
DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Alliance/Miscellaneous CEVEC and Beckman Research Institute of City of Hope enter into a cooperation and license agreement on CEVEC's proprietary...
-
Company Announcement Arzerra now approved by U.S. FDA for use for extended treatment of patients with recurrent or progressive CLL Approval based on data from interim analysis of Phase III...
-
Selskabsmeddelelse Arzerra er blevet godkendt af de amerikanske sundhedsmyndigheder til forlænget behandling af patienter med recidiverende eller progressiv CLL Godkendelsen er baseret på...